Showing results (31-40 of 180) with videos related to

Sort By:
Pageof 18
British Journal of Haematology|May 25, 2002
Dose escalation therapy in previously untreated patients with multiple myeloma following Z-Dex induction treatmentAndrew D Clark, Kenneth W Douglas, Lyndsay D Mitchell, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 20, 2018
A Comparison of the Efficacy of Immunomodulatory-containing Regimens in Relapsed/Refractory Multiple Myeloma: A Network Meta-analysisMeletios Athanasios Dimopoulos, Jonathan L Kaufman, Darrell White, et al.
Ejhaem|December 18, 2024
The UK consensus supporting effective introduction of novel treatments for multiple myeloma in the National Health ServiceRakesh Popat, Supratik Basu, Sarah Henshaw, et al.
Cancer Management and Research|July 24, 2024
UK Stakeholder Perspectives on Surrogate Endpoints in Cancer, and the Potential for UK Real-World Datasets to Validate Their Use in Decision-MakingDavid Baldwin, Jonathan Carmichael, Gordon Cook, et al.
British Journal of Haematology|April 2, 2005
A third course of anti-thymocyte globulin in aplastic anaemia is only beneficial in previous respondersVikas Gupta, Edward C Gordon-Smith, Gordon Cook, et al.
The Lancet. Haematology|November 16, 2016
Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trialRakesh Popat, Sarah R Brown, Louise Flanagan, et al.
BMJ Open|February 23, 2021
Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohortMaxine Je Lamb, Alexandra Smith, Daniel Painter, et al.
Blood|October 22, 2005
Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation StudyJulio Delgado, Kirsty Thomson, Nigel Russell, et al.
British Journal of Haematology|February 16, 2008
IgM myeloma: a rare entity characterized by a CD20-CD56-CD117- immunophenotype and the t(11;14)Sylvia Feyler, Sheila J M O'Connor, Andy C Rawstron, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 20, 2010
Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for relapsed and refractory mantle cell lymphoma (MCL): a study of the British Society for Blood and Marrow TransplantationGordon Cook, Graeme M Smith, Keiren Kirkland, et al.
Pageof 18